On the recordMay 3, 2021
Developing therapies will not happen unless we somehow find a way to incentivize our partners in the pharmaceutical industry.
Source
congress.govEditor's note · Context
Guthrie emphasizes the need for incentives to develop new therapies.
Share & report
More from James Guthrie
Dec 1, 2021
I am really frustrated that we failed to come up with and join together to permanently schedule fentanyl analogs.
May 11, 2021
The Biden administration must get a better grasp on handling this crisis and the massive influx of UC referrals.
Jul 28, 2021
Thank you, Madam Chair, for the recognition, and the first question is for Dr. Koroshetz and Dr. Hodes.
Other voices in this conversation
